Blood cancer Clinical Trials in Farmington, CT
As of June 2026, 2 paid clinical trials are recruiting for Blood cancer in Farmington, Connecticut. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
2 clinical trials for Blood cancer
·Clear filters·↓ Download CSVA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
About research studies in Farmington
Farmington has approximately 68 recruiting research studies across a wide range of therapeutic areas. Connecticut hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Farmington
Researchers run research studies in Farmington, CT at 28 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UConn Health | Aging, Focal Epilepsy, Alcohol Use Disorder | 17 |
| University of Connecticut Health Center | Ischemia, Myocardial Infarction, Acute Decompensated Heart Failure | 13 |
| University of Connecticut | Huntington's Disease, Multiple Myeloma, Myasthenia Gravis | 5 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Clinical Study Site | Glycogen Storage Disease Type Ia | 1 |
| Connecticut Children's | Macromastia, Post-operative Pain | 1 |
| Connecticut Children's Medical Center | Spinal Muscular Atrophy (SMA) | 1 |
| Connecticut Children's Sports Physical Therapy | Anterior Cruciate Ligament Injuries, Knee Injuries, Quadriceps Muscle Atrophy | 1 |
| Connecticut Office of the Chief Medical Examiner | Grief, Grief Disorder, Prolonged, Overdose Accidental | 1 |
| Connecticut Surgery Center | Lumbar Spinal Stenosis | 1 |
| Department of Orthodontics | Tooth Crowding | 1 |
| GSK Investigational Site | Neoplasms, Head and Neck | 1 |
| Local Institution - 0001 | Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE), Systemic Lupus Erythematosus (SLE) | 1 |
| Local Institution - 0380 | Relapsed or Refractory Multiple Myeloma | 1 |
| New England Sickle Cell Institute, University of Connecticut | Sickle Cell Anaemia, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Sickle Cell Anemia Crisis | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| The Center for Advanced Reproductive Services, P.C. | Infertility, Male Factor Infertility | 1 |
| UCONN Health Dermatology | Chronic Spontaneous Urticaria (CSU) | 1 |
| UConn Health - Farmington | Dermatitis Atopic | 1 |
| UConn Health - The Carole and Ray Neag Comprehensive Cancer Center | Eosinophilic Esophagitis (EoE) | 1 |
| UConn Health / John Dempsey Hospital | Heart Failure With Preserved Ejection Fraction | 1 |
| UConn Health Center | Depressive Disorder, Major | 1 |
| UConn Health Main | Hidradenitis Suppurativa | 1 |
| UConn Health-Farmington (University of Connecticut Health Center (UCHC)) | Advanced Melanoma | 1 |
| University of Connecticut Health | Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension | 1 |
| University of Connecticut Health Center (UCHC) | Keloid | 1 |
| University of Connecticut Health Center - Department of Medicine | Generalized Myasthenia Gravis | 1 |
| University of Connecticut School of Medicine Psychiatry Department | Major Depressive Disorder | 1 |
Active & Upcoming Studies in Farmington (2026)
Recruiting trials in Farmington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Neurology & pain (8 active studies)
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease · Phase 2, Phase 3 · Biohaven Therapeutics Ltd.
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Cancer & tumors (7 active studies)
- A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer · Phase 3 · AstraZeneca
Cardiovascular (5 active studies)
Mental health & behavior (3 active studies)
- Families Left Behind · RAND
- Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder · Phase 2 · Intra-Cellular Therapies, Inc.
Diabetes & metabolic (1 active study)
Pediatric (1 active study)
Common conditions studied in Farmington
- Major Depressive Disorder (4 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Aging (3 active studies). Recruiting Aging studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Focal Epilepsy (2 active studies). Epilepsy research focuses on new anti-seizure medications, neuromodulation devices, and precision therapies for genetic epilepsies.
- Generalized Anxiety Disorder (2 active studies). Anxiety trials investigate novel anxiolytics, digital interventions, and psychedelic-assisted therapies for generalized and social anxiety disorders.
- Ischemia (2 active studies). Recruiting Ischemia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Multiple Myeloma (2 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Farmington
- UConn Health
- Biohaven Therapeutics Ltd.
- Janssen Research & Development, LLC
- Intra-Cellular Therapies, Inc.
- AstraZeneca
Local regulations and guidelines
Clinical trials in Connecticut are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Connecticut research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Farmington. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Farmington
Hipa.ai aggregates every recruiting study in Farmington from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Farmington?
There are approximately 68 recruiting clinical trials in Farmington, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Farmington pay participants?
Most recruiting trials in Farmington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Farmington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Farmington?
The most common conditions under active study in Farmington include Major Depressive Disorder (4), Aging (3), Focal Epilepsy (2), Generalized Anxiety Disorder (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Farmington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Farmington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Farmington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Farmington?
Recruiting research sites in Farmington include UConn Health, University of Connecticut Health Center, University of Connecticut, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Farmington right now?
The largest active categories in Farmington are Neurology & pain (8), Cancer & tumors (7), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.